Taking aspirin was first linked to a lower risk of colorectal cancer in 1988, but the research into its anti-tumour potential ...

For decades, aspirin has been known as a go-to painkiller. New research reveals how it may also help fight cancer. While previous research hinted at a link between aspirin use and improved cancer ...

New research further solidifies findings that aspirin could be a powerful anti-cancer drug, at least in some specific cases.

Could aspirin keep cancer from spreading? A new study from the University of Cambridge suggests that the common pain medication could have this surprise benefit. Experts weigh in.

Aspirin use in patients with PIK3CA-mutated colorectal cancer reduces recurrence risk by over 50%. | Drug Discovery And Development ...

Aspirin, a widely available and inexpensive drug, has failed to improve survival or reduce recurrence rates in women with early-stage but high-risk breast cancer, according to a Harvard-led clinical ...

Aspirin could be a powerful weapon against Britain's biggest cancer killer, experts said yesterday. A U.S. study found that the painkiller can help cut the chance of developing the most common ...

A large-scale, international, multicentre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal cancer has concluded. Led by Singapore clinician-scientists, the ASCOLT ...